Le Lézard
Classified in: Health
Subject: SVY

Global Esophageal Cancer Epidemiology and Patient Flow Analysis - 2017


LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Esophageal Cancer patients study in a new report 'Global Esophageal Cancer Epidemiology and Patient Flow Analysis - 2017'.

Download the full report: https://www.reportbuyer.com/product/3895249


The report provides insights into Esophageal Cancer epidemiology, Esophageal Cancer diagnosed patients, and Esophageal Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Esophageal Cancer derived from epidemiological analysis, percentage of patients diagnosed with Esophageal Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Esophageal Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Esophageal Cancer prevalence, Esophageal Cancer diagnosis rate, and Esophageal Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Esophageal Cancer Patient Flow
- Esophageal Cancer Prevalence
- Esophageal Cancer Diagnosed Patients
- Esophageal Cancer Treated Patients

Download the full report: https://www.reportbuyer.com/product/3895249

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 11:03
Vajra Coffee Offers Chemical Free Naturally Decaffeinated Coffee
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for Alltm
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSAtm(vibegron) in overactive bladder syndrome
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC Partners with HearMe on UN World Day for Safety and Health at Work
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivitytm Blood Testing for Alzheimer's Disease and Brain Research Market
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...

More news about Health...


News published on and distributed by: